Autolus Therapeutics Statistics
Total Valuation
AUTL has a market cap or net worth of $452.44 million. The enterprise value is $577.65 million.
Important Dates
The last earnings date was Thursday, May 14, 2026, before market open.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AUTL has 266.14 million shares outstanding. The number of shares has decreased by -0.00% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 266.14M |
| Shares Change (YoY) | -0.00% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 6.12% |
| Owned by Institutions (%) | 18.67% |
| Float | 82.30M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.88 |
| Forward PS | 3.24 |
| PB Ratio | 4.16 |
| P/TBV Ratio | 4.16 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.24 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.80, with a Debt / Equity ratio of 3.26.
| Current Ratio | 5.80 |
| Quick Ratio | 3.61 |
| Debt / Equity | 3.26 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6.24 |
Financial Efficiency
Return on equity (ROE) is -120.42% and return on invested capital (ROIC) is -28.85%.
| Return on Equity (ROE) | -120.42% |
| Return on Assets (ROA) | -25.96% |
| Return on Invested Capital (ROIC) | -28.85% |
| Return on Capital Employed (ROCE) | -57.06% |
| Weighted Average Cost of Capital (WACC) | 12.47% |
| Revenue Per Employee | $122,844 |
| Profits Per Employee | -$383,243 |
| Employee Count | 754 |
| Asset Turnover | 0.15 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, AUTL has paid $610,000 in taxes.
| Income Tax | 610,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +15.65% in the last 52 weeks. The beta is 1.93, so AUTL's price volatility has been higher than the market average.
| Beta (5Y) | 1.93 |
| 52-Week Price Change | +15.65% |
| 50-Day Moving Average | 1.50 |
| 200-Day Moving Average | 1.55 |
| Relative Strength Index (RSI) | 56.66 |
| Average Volume (20 Days) | 1,636,921 |
Short Selling Information
The latest short interest is 13.09 million, so 7.58% of the outstanding shares have been sold short.
| Short Interest | 13.09M |
| Short Previous Month | 14.21M |
| Short % of Shares Out | 7.58% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 9.12 |
Income Statement
In the last 12 months, AUTL had revenue of $92.62 million and -$288.97 million in losses. Loss per share was -$1.09.
| Revenue | 92.62M |
| Gross Profit | -115.85M |
| Operating Income | -264.47M |
| Pretax Income | -288.36M |
| Net Income | -288.97M |
| EBITDA | -254.48M |
| EBIT | -264.47M |
| Loss Per Share | -$1.09 |
Full Income StatementBalance Sheet
The company has $229.43 million in cash and $354.64 million in debt, with a net cash position of -$125.21 million or -$0.47 per share.
| Cash & Cash Equivalents | 229.43M |
| Total Debt | 354.64M |
| Net Cash | -125.21M |
| Net Cash Per Share | -$0.47 |
| Equity (Book Value) | 108.83M |
| Book Value Per Share | 0.41 |
| Working Capital | 305.24M |
Full Balance SheetCash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 9.99M |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | -125.08% |
| Operating Margin | -285.53% |
| Pretax Margin | -311.32% |
| Profit Margin | n/a |
| EBITDA Margin | -274.74% |
| EBIT Margin | -285.53% |
| FCF Margin | n/a |
Dividends & Yields
AUTL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.00% |
| Shareholder Yield | n/a |
| Earnings Yield | -63.87% |
| FCF Yield | n/a |
Analyst Forecast
The average price target for AUTL is $8.71, which is 412.35% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $8.71 |
| Price Target Difference | 412.35% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 38.94% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |
